promensil original 30s reviews

by

promensil original 30s reviews

Naturally occurring red clover isoflavones, highly recommended for women throughout menopause as a maintenance dose but can be used peri-menopause and post-menopause.

Promensil Original 30s

Naturally occurring red clover isoflavones, highly recommended for women throughout menopause as a maintenance dose but can be used peri-menopause and post-menopause.

Key Facts:

  • Maintenance dose (40mg of red clover isoflavones)
  • Use throughout menopause
  • Contains 4 isoflavones
  • High bioavailability
  • Suitable for Vegans & Vegetarians
  • Does not cause weight gain

9/10 women agree that Promensil works for them!
Share your experience and leave a review today.

*Survey carried out by PharmaCare on 501 women who had tried Promensil

  • Description
  • Directions of Use
  • How it Works
  • Nutritional Information
  • Reviews (1)

Get up to 15% off* or get the better offer price when you opt-in for recurring deliveries with Subscribe & Save. Available on UK deliveries only.

Customers also bought

Promensil Original Strength Tablets are daily dietary supplements formulated specifically for women during and after the menopause, as they can help to support and maintain general heath and well-being in women; they are made using red clover isoflavones which has been shown to help maintain healthy bones and cholesterol levels to keep your fit and healthy at all times.

Promensil Original Strength Tablets contain:

Dicalcium phosphate (bulking agent), Red clover (Trifolium pratense) extract, Microcrystalline cellulose (bulking agent), Colloidal silica (bulking agent), Magnesium stearate (anti-caking agent), Croscarmellose sodium (emulsifier), Titanium dioxide (colour), Mixed tocopherols (anti-oxidants), Caramel (colour), Carnauba wax (glazing agent).

Disclaimer

The views expressed are those of our customers. If you require advice on a condition or treatment, please contact your doctor or pharmacist. For any questions regarding the products, please contact us. Please note: due to advertising regulations, not all product reviews can be displayed. Please be advised that people respond to products differently and you should always read the label.

Promensil Original (available in 30s and 60s)

  • Shop as normal and proceed to checkout
  • Select SplitPay as your payment method
  • Login to your SplitPay account, or signup for an instant approval decision
  • Your payment schedule will be emailed to you and your instalments will be deducted automatically when due. Easy!
  • Description
  • Additional information
  • Reviews (0)
  • How it works

Promensil Original 60s ( 2 month supply )

Promensil Original (available in 30s and 60s)

Product description:
Promensil Original
Naturally occurring red clover isoflavones for women during and after the menopause.

Highly recommended throughout the menopause as a maintenance dose. Promensil Original is Specifically formulated to provide 40mg of high strength, standardised Red Clover Isoflavones (phytoestrogens) which work from within for long-term hormonal balance and dietary support during the menopause.

Key facts:

  • Maintenance dose (40mg of red clover isoflavones)
  • Use throughout menopause
  • Contains 4 isoflavones
  • High bioavailability
  • Suitable for vegans and vegetarians
  • Does not cause weight gain

Features & benefits:
For women who look for alternative solutions for menopause. Promensil is a dietary supplement based on red clover isoflavones specifically developed to provide support and wellbeing for women during and after the menopause. Promensil’s red clover isoflavones are naturally occurring plant oestrogens that have been specifically extracted and are not chemically synthesised.

Promensil is the most extensively studied menopause supplement. Promensil has been used in international scientific research into effects of red clover supplementation during menopause for over 20 years.

Directions of use:
Take one or two tablets daily with your main meal and a cold drink, continuously at around the same time each day or as directed by your healthcare professional. Initially we recommend a minimum of 12 weeks intake to feel the full effect.

Cautions:
Do not exceed the recommended dosage. Food supplements should not replace a balanced diet and healthy lifestyle. If you are under medical supervision, please consult your healthcare professional before use. Not for use by pregnant or lactating women. Keep out of sight and reach of children. Store below 25°C in a dry place, out of direct sunlight.


Ingredients:
Bulking agents (Dicalcium Phosphate, Microcrystalline Cellulose), Red Clover Extract (Trifolium Pratense), Tablet Coating (Hydroxypropylmethyl Cellulose, Colours: Titanium Dioxide & Iron Oxides, Glazing Agent: Polyethylene Glycol), Anti-caking agents (Silicon Dioxide, Magnesium Stearate), Antioxidant (Alpha Tocopherol), Emulsifier (Cross-linked Sodium Carboxymethyl Cellulose).

Lipovac M, Chedraui P, Gruenhut C, et al. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 2010;65:258-61. View abstract.

Dosing

Boocock DJ, Faust GE, Patel KR, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007;16:1246-52. View abstract.

Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 2000;141:3657-67.

Bujanda L, Garcia-Barcina M, Gutierrez-de Juan V, et al. Effect of resveratrol on alcohol-induced mortality and liver lesions in mice. BMC Gastroenterol 2006;6:35. View abstract.

Carbo N, Costelli P, Baccino FM, et al. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun 1999;254:739-43. View abstract.

Abernethy K, Brockie J, Suffling K, and et al. An open study of the effects of a 40mg isoflavone food supplement (derived from Red Clover), on menopausal symptoms. The British Menopause Society (2001). 2001;

Atkinson C, Compston JE, Robins SP, and et al. The effects of isoflavone phytoestrogens on bone: preliminary results from a large randomized controlled trial. Endocr Soc Annu Meet Program 2000;82:196.

Baber R, Clifton Bligh P, Fulcher G, and et al. The effect of an isoflavone extract (PO81) on serum lipids, forearm bone density and endometrial thickness in postmenopausal women [Abstract]. Proceedings of the North American Menopause Society (New York, 1999).

Barnes, S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995;125(3 Suppl):777S-783S. View abstract.

Blakesmith, S. J., Lyons-Wall, P. M., Joannou, G. E., Petocz, P., and Samman, S. Urinary isoflavonoid excretion is inversely associated with the ratio of protein to dietary fibre intake in young women. Eur.J Clin Nutr 2005;59(2):284-290. View abstract.

Burdette, J. E., Liu, J., Lantvit, D., Lim, E., Booth, N., Bhat, K. P., Hedayat, S., van Breemen, R. B., Constantinou, A. I., Pezzuto, J. M., Farnsworth, N. R., and Bolton, J. L. Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats. J Nutr 2002;132(1):27-30. View abstract.

Domon, O. E., McGarrity, L. J., Bishop, M., Yoshioka, M., Chen, J. J., and Morris, S. M. Evaluation of the genotoxicity of the phytoestrogen, coumestrol, in AHH- 1 TK(+/-) human lymphoblastoid cells. Mutat.Res 3-1-2001;474(1-2):129-137. View abstract.

Finking, G., Wohlfrom, M., Lenz, C., Wolkenhauer, M., Eberle, C., and Hanke, H. The phytoestrogens Genistein and Daidzein, and 17 beta-estradiol inhibit development of neointima in aortas from male and female rabbits in vitro after injury. Coron.Artery Dis. 1999;10(8):607-615. View abstract.

Friedman, J. A., Taylor, S. A., McDermott, W., and Alikhani, P. Multifocal and recurrent subarachnoid hemorrhage due to an herbal supplement containing natural coumarins. Neurocrit.Care 2007;7(1):76-80. View abstract.

Gerber G, Lowe FC, and Spigelman S. The use of a standardized extract of red clover isoflavones for the alleviation of BPH symptoms. The Endocrine Society’s 82nd Annual Meeting 2000;82:2359.

Hamilton-Reeves, J. M., Vazquez, G., Duval, S. J., Phipps, W. R., Kurzer, M. S., and Messina, M. J. Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis. Fertil.Steril. 2010;94(3):997-1007. View abstract.

Hooper, L., Madhavan, G., Tice, J. A., Leinster, S. J., and Cassidy, A. Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Hum.Reprod.Update. 2010;16(6):745-760. View abstract.

Jarred, R. A., Keikha, M., Dowling, C., McPherson, S. J., Clare, A. M., Husband, A. J., Pedersen, J. S., Frydenberg, M., and Risbridger, G. P. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol.Biomarkers Prev. 2002;11(12):1689-1696. View abstract.

Jeri AR. The effect of isoflavone phytoestrogens in relieving hot flushes in Peruvian post menopausal women. 9th International Menopause Society World Congress on the Menopause (1999).

Jeri, A. R. The use of an isoflavone supplement to relieve hot flushes. Female Patient 2002;27:35-37.

Kelley, K. W. and Carroll, D. G. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women. J.Am.Pharm.Assoc.(2003.) 2010;50(5):e106-e115. View abstract.

Knight DC. The effect of Promensil, an isoflavone extract, on menopausal symptoms . Climacteric 1999;2:79-84.

Knight, D. C. and Eden, J. A. A review of the clinical effects of phytoestrogens. Obstet.Gynecol. 1996;87(5 Pt 2):897-904. View abstract.

Kolodziejczyk-Czepas, J. Trifolium species-derived substances and extracts–biological activity and prospects for medicinal applications. J.Ethnopharmacol. 8-30-2012;143(1):14-23. View abstract.

Leach, M. J. and Moore, V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane.Database.Syst.Rev. 2012;9:CD007244. View abstract.

Lee, C. C., Bloem, C. J., Kasa-Vubu, J. Z., and Liang, L. J. Effect of oral phytoestrogen on androgenicity and insulin sensitivity in postmenopausal women. Diabetes Obes.Metab 2012;14(4):315-319. View abstract.

Lipovac, M., Chedraui, P., Gruenhut, C., Gocan, A., Kurz, C., Neuber, B., and Imhof, M. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecol.Endocrinol. 2012;28(3):203-207. View abstract.

Lovati, M. R., Manzoni, C., Canavesi, A., Sirtori, M., Vaccarino, V., Marchi, M., Gaddi, G., and Sirtori, C. R. Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 1987;80(5):1498-1502. View abstract.

Ma, H., Sullivan-Halley, J., Smith, A. W., Neuhouser, M. L., Alfano, C. M., Meeske, K., George, S. M., McTiernan, A., McKean-Cowdin, R., Baumgartner, K. B., Ballard-Barbash, R., and Bernstein, L. Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report. BMC.Complement Altern.Med. 2011;11:109. View abstract.

Nachtigall LB, La Grega L, Lee WW, and et al. The effects of isoflavones derived from red clover on vasomotor symptoms and endometrial thickness. 9th International Menopause Society World Congress on the Menopause. 1999;331-336.

Nissan, H. P., Lu, J., Booth, N. L., Yamamura, H. I., Farnsworth, N. R., and Wang, Z. J. A red clover (Trifolium pratense) phase II clinical extract possesses opiate activity. J Ethnopharmacol 5-30-2007;112(1):207-210. View abstract.

Peterson, G. and Barnes, S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 1993;22(4):335-345. View abstract.

Peterson, G. and Barnes, S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem.Biophys.Res.Commun. 8-30-1991;179(1):661-667. View abstract.

Pitkin, J. Alternative and complementary therapies for the menopause. Menopause.Int. 2012;18(1):20-27. View abstract.

Rosenberg Zand, R. S., Jenkins, D. J., and Diamandis, E. P. Effects of natural products and nutraceuticals on steroid hormone-regulated gene expression. Clin Chim.Acta 2001;312(1-2):213-219. View abstract.

Samman, S., Koh, H. S., Flood, V. M., Blakesmith, S. J., Petocz, P., and Lyons-Wall, P. M. Red clover (Trifolium pratense) isoflavones and serum homocysteine in premenopausal women: a pilot study. J.Womens Health (Larchmt.) 2009;18(11):1813-1816. View abstract.

Shulman, L. P., Banuvar, S., Fong, H. H., and Farnsworth, N. R. Discussion of a well-designed clinical trial which did not demonstrate effectiveness: UIC center for botanical dietary supplements research study of black cohosh and red clover. Fitoterapia 2011;82(1):88-91. View abstract.

Stephens, F. O. Phytoestrogens and prostate cancer: possible preventive role. Med J Aust. 8-4-1997;167(3):138-140. View abstract.

Suh, K. S., Koh, G., Park, C. Y., Woo, J. T., Kim, S. W., Kim, J. W., Park, I. K., and Kim, Y. S. Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry 2003;63(2):209-215. View abstract.

Tice J, Cummings SR Ettinger B et al. Few adverse effects of two red clover extracts rich in phytoestrogens: a multicenter, placebo-controlled trial. Alt Ther 2001;7:S33.

Tomar, R. S. and Shiao, R. Early life and adult exposure to isoflavones and breast cancer risk. J.Environ.Sci.Health C.Environ.Carcinog.Ecotoxicol.Rev. 2008;26(2):113-173. View abstract.

Umland, E. M. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J.Manag.Care Pharm. 2008;14(3 Suppl):14-19. View abstract.

Vrieling, A., Rookus, M. A., Kampman, E., Bonfrer, J. M., Korse, C. M., van Doorn, J., Lampe, J. W., Cats, A., Witteman, B. J., van Leeuwen, F. E., van’t Veer, L. J., and Voskuil, D. W. Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk. J Nutr 2007;137(2):379-383. View abstract.

Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82. View abstract.

Anon. The role of isoflavones in menopausal health: consensus opinion of the North American Menopause Society. Menopause 2000;7:215-29.. View abstract.

Anthony MS. Soy and cardiovascular disease: Cholesterol lowering and beyond. J Nutr 2000;130:662S-3S. View abstract.

Atkinson C, Compston JE, Day NE, et al. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2004;79:326-33. View abstract.

Atkinson C, Oosthuizen W, Scollen S, et al. Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women. J Nutr 2004;134:1759-64. View abstract.

Atkinson C, Warren RM, Sala E, et al. Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res 2004;6:R170-R179. View abstract.

Baber RJ, Templeman C, Morton T, et al. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92.. View abstract.

Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90. View abstract.

Barnes S, Kim H, Darley-Usmar V, et al. Beyond ERalpha and ERbeta: Estrogen receptor binding is only part of the isoflavone story. J Nutr 2000;130:656S-7S. View abstract.

Blakesmith SJ, Lyons-Wall PM, George C, et al. Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. Br J Nutr 2003;89(4):467-474. View abstract.

Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000;7:273-82. View abstract.

Campbell MJ, Woodside JV, Honour JW, et al. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. Eur J Clin Nutr 2004;58(1):173-179. View abstract.

Cassady JM, Zennie TM, Chae YH, et al. Use of a mammalian cell culture benzo(a)pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L. Cancer Res 1988;48:6257-61. View abstract.

Chedraui P, San Miguel G, Hidalgo L, et al. Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index. Gynecol Endocrinol 2008;24(11):620-624. View abstract.

Chen L, Choi J, Leonard SW, et al. No Clinically Relevant Pharmacokinetic Interactions of a Red Clover Dietary Supplement with Cytochrome P450 Enzymes in Women. J Agric Food Chem. 2020;68(47):13929-13939. View abstract.

Coon JT, Pittler MH, Ernst E. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine 2007;14(2-3):153-159. View abstract.

del Giorno C, Fonseca AM, Bagnoli VR, et al. Effects of Trifolium pratense on the climacteric and sexual symptoms in postmenopause women. Rev Assoc Med Bras 2010;56(5):558-562. View abstract.

Duncan AM, Underhill KE, Xu X, et al. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999;84:3479-84. View abstract.

Electronic Code of Federal Regulations. Title 21. Part 182 — Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182

Ferraris C, Ballestra B, Listorti C, et al. Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen. Breast Cancer Res Treat 2020;180(1):157-65. doi: 10.1007/s10549-020-05534-4. View abstract.

Freeland-Graves JH, Lin PH. Plasma uptake of manganese as affected by oral loads of manganese, calcium, milk, phosphorus, copper, and zinc. J Am Coll Nutr 1991;10:38-43. View abstract.

Geller J, Sionit L, Partido C, et al. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 1998;34:75-9. View abstract.

Geller SE, Shulman LP, van Breemen RB, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16:1156-66. View abstract.

Gerber G, Lowe FC, Spigelman S. The use of a standardized extract of red clover isoflavones for the alleviation of BPH symptoms. Endocrine Soc 82nd Ann Mtg, Toronto, CAN 2000;Jun 21-4:abstract 2359.

Ghazanfarpour M, Sadeghi R, Roudsari RL, Khorsand I, Khadivzadeh T, Muoio B. Red clover for treatment of hot flashes and menopausal symptoms: a systematic review and meta-analysis. J Obstet Gynaecol. 2015;36:301-311. View abstract.

Ginsburg J, Prelevic GM. Lack of significant hormonal effects and controlled trials of phyto-oestrogens. Lancet 2000;355:163-4. View abstract.

Guerrero JA, Lozano ML, Castillo J, et al. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost 2005;3(2):369-376. View abstract.

Hale GE, Hughes CL, Robboy SJ, et al. A doubleblind randomized study on the effects of red clover isoflavones on the endometrium. Menopause 2001;8:338-46. View abstract.

Hargreaves DF, Potten CS, Harding C, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999;84:4017-24. View abstract.

Hidalgo LA, Chedraui PA, Morocho N, et al. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecol Endocrinol 2005;21(5):257-264. View abstract.

Hodgson JM, Puddey IB, Beilin LJ, et al. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr 1998;128:728-32. View abstract.

Horn-Ross PL, John EM, Canchola AJ, et al. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2003;95:1158-64.. View abstract.

Howes J, Waring M, Huang L, Howes LG. Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense). J Altern Complement Med 2002;8:135-42. View abstract.

Howes JB, Bray K, Lorenz L, et al. The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women. Climacteric 2004;7(1):70-77. View abstract.

Howes JB, Sullivan D, Lai N, et al. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of postmenopausal women with mild to moderate hypercholesterolemia. Atherosclerosis 2000;152:143-7. View abstract.

Howes JB, Tran D, Brillante D, Howes LG. Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes. Diabetes Obes Metab 2003;5(5):325-332. View abstract.

Imhof M, Gocan A, Reithmayr F, et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas 2006;55(1):76-81. View abstract.

Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997;350-:990-4. View abstract.

Ingram DM, Hickling C, West L, et al. A double-blind randomized controlled trial of isoflavones in the treatment of cyclical mastalgia. The Breast 2002;11:170-4. View abstract.

Janssen K, Mensink RP, Cox FJ, et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998;67:255-62. View abstract.

Jarred RA, McPherson SJ, Jones ME, et al. Anti-androgenic action by red clover-derived dietary isoflavones reduces non-malignant prostate enlargement in aromatase knockout (ArKo) mice. Prostate 2003;56:54-64. View abstract.

Kanadys W, Baranska A, Blaszczuk A, et al. Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2021;13(4):1258. View abstract.

Kanadys W, Baranska A, Jedrych M, Religioni U, Janiszewska M. Effects of red clover (Trifolium pratense) isoflavones on the lipid profile of perimenopausal and postmenopausal women-A systematic review and meta-analysis. Maturitas 2020;132:7-16. doi: 10.1016/j.maturitas.2019.11.001. View abstract.

Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peters PH. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 2004;79:282-8. View abstract.

Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.. View abstract.

Kondo K, Suzuki Y, Ikeda Y, Umemura K. Genistein, an isoflavone included in soy, inhibits thrombotic vessel occlusion in the mouse femoral artery and in vitro platelet aggregation. Eur J Pharmacol 2002;455(1):53-57. View abstract.

Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004;104:824-36. View abstract.

Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet 1995;346:270-4. View abstract.

Kurzer MS, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997;17:353-81. View abstract.

Lambert MNT, Thorup AC, Hansen ESS, Jeppesn PB. Combined red clover isoflavonese and probiotics potently reduce menopausal vasomotor symptoms. PLoS One. 2017 Jun 7;12(6):e0176590. View abstract.

Le Bail JC, Champavier Y, Chulia AJ, Habrioux G. Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci 2000;66:1281-91. View abstract.

Lipovac M, Chedraui P, Gruenhut C, et al. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 2010;65:258-61. View abstract.

Lissin LW, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 2000;35:1403-10. View abstract.

Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001;49:2472-9.. View abstract.

Loing E, Lachance R, Ollier V, Hocquaux M. A new strategy to modulate alopecia using a combination of two specific and unique ingredients. J Cosmet Sci 2013;64(1):45-58. View abstract.

Maki PM, Rubin LH, Fornelli D, et al. Effects of botanicals and combined hormone therapy on cognition in postmenopausal women. Menopause 2009;16:1167-77. View abstract.

Masuda T, Ino Y, Hirai A, et al. Effects of isoflavone-rich red clover extract on blood glucose level: A randomized, double-blind, placebo-controlled trial. J Food Sci. 2021;86(4):1393-1399. View abstract.

Moghissi KS. Risks and benefits of nutritional supplements during pregnancy. Obstet Gynecol 1981;58:68S-78S. View abstract.

Mokhtari M, Yousefi M, Bazaz MM, Rakhshandeh H, Vahid H, Ariamanesh AS. The efficacy of topical red clover oil on knee osteoarthritis: A pilot prospective randomized triple-blind placebo-controlled clinical trial. Phytother Res 2020 Mar 12. doi: 10.1002/ptr.6650. Online ahead of print. View abstract.

Myers SP, Vigar V. Effects of a standardized extract of Trifolium pretense (Promensil) at a dosage of 80mg in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine. 2017 Jan 15;24:141-47. View abstract.

Nelsen J, Barrette E, Tsouronix C, et al. Red clover (Trifolium pratense) monograph: A clinical decision support tool. J Herb Pharmacother 2002;2:49-72. View abstract.

Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057-71. View abstract.

Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999;84:895-8. View abstract.

O’Dell BL. Mineral interactions relevant to nutrient requirements. J Nutr 1989;119:1832-8. View abstract.

Orr A and Parker R. Red clover causing symptoms suggestive of methotrexate toxicity in a patient on high-dose methotrexate. Menopause Int. 2013;19(3):133-134.

Polini N, Rauschemberger MB, Mendiberri J, et al. Effect of genistein and raloxifene on vascular dependent platelet aggregation. Mol Cell Endocrinol 2007;267(1-2):55-62. View abstract.

Puschner B, Galey FD, Holstege DM, et al. Sweet clover poisoning in dairy cattle in California. J Am Vet Med Assoc 1998;212:857-9.. View abstract.

Risbridger GP, Wang H, Frydenberg M, Husband A. The in vivo effect of red clover diet on ventral prostate growth in adult male mice. Reprod Fertil Dev 2001;13:325-9. View abstract.

Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). 2015.

Roberts DW, Doerge DR, Churchwell MI, et al. Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover). J Agric Food Chem 2004;52:6623-32. View abstract.

Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol 2007;23:117-22. View abstract.

Samman S, Lyons Wall PM, Chan GS, et al. The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 1999;147(2):277-283. View abstract.

Schult TM, Ensrud KE, Blackwell T, et al. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas 2004;48:209-18. View abstract.

Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999;129:758S-67S. View abstract.

Setchell KD, Gosselin SJ, Welsh MB, et al. Dietary estrogens–a probable cause of infertility and liver disease in captive cheetahs. Gastroenterol 1987;93:225-33. View abstract.

Setchell KD. Absorption and metabolism of soy isoflavones-from food to dietary supplements and adults to infants. J Nutr 2000;130:654S-5S. View abstract.

Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68:1333S-46S. View abstract.

Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000;85:1297-301. View abstract.

Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000;85:1297-301. View abstract.

Terzic MM, Dotlic J, Maricic S, et al. Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women. J Obstet Gynaecol Res 2009;35(6):1091-1095. View abstract.

This P, De La Rochefordiere A, Clough K, et al. Phytoestrogens after breast cancer. Endocr Relat Cancer 2001;8:129-34. View abstract.

Tice J, Cummings SR, Ettinger B, et al. Few adverse effects of two red clover extracts rich in phytoestrogens: a multicenter, placebo-controlled trial. Alt Ther 2001;7:S33.

Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) study: a randomized controlled trial. JAMA 2003;290:207-14.. View abstract.

Umland EM, Cauffield JS, Kirk JK, et al. Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women. Pharmacotherapy 2000;20:981-90. View abstract.

Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;18:2273-81. View abstract.

van de Weijer and Barentsen R. Isoflavones from red clover (Promensil®) significantly reduce hot flashes compared with placebo. Poster presented at: The North American Menopause Society’s 12th Annual Meeting (2001).

van de Weijer P, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187-93. View abstract.

Villaseca P. Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice. Climacteric 2012;15(2):115-124. View abstract.

Vincent A, Fitzpatrick LA. Soy isoflavones: are they useful in menopause? Mayo Clin Proc 2000;75:1174-84. View abstract.

Weaver CM, Martin BR, Jackson GS, et al. Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. J Clin Endocrinol Metab 2009;94(10):3798-3805. View abstract.

Wuttke W, Jarry H, Seidlova-Wuttke D. Plant-derived alternative treatments for the aging male: facts and myths. Aging Male 2010;13(2):75-81. View abstract.

Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993;53:5815-21. View abstract.

Zand RS, Jenkins DJ, Diamandis EP. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 2000;62:35-49. View abstract.